Abstract
Preterm births are rising, and neonatal care provisions are advancing with research and technology. Intravenous Magnesium Sulphate (MgSO4), given to the mother when preterm birth is expected or planned, will help protect the baby’s brain and reduce the incidence of cerebral palsy. Cerebral palsy is a lifelong condition with varying degrees of severity and disability. The PReCePT project is now a national project and should be delivered in all NHS hospitals across the country.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
